Last checked at 
(Alliance News) - Physiomics PLC on Tuesday said it traded in line with analyst expectations in its recently completed financial year.
Shares in Physiomics were down 5.4% at 3.22 pence in midday trading.
The company, which provides technology to predict the effects of cancer treatment, said its comment was based on its unaudited management accounts for its year that ended June 30. It didn't provide any detail.
Physiomics will publish its final audited results for the recent financial year in the week beginning September 30.
